Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...
European regulators suspended the approval of Pfizer Inc.’s sickle cell anemia drug, Oxbryta, citing a higher rate of disease ...
U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...
Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and ...
The program will bring specialists from hospital medicine, general medicine, psychiatry and pain medicine under one roof.
September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
This month Genomics England is marking Sickle Cell Awareness Month, which aims to bring greater visibility of the genetic ...
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...